Clinical Orthopaedics and Related Research ®

A Publication of The Association of Bone and Joint Surgeons ®

Tumor 247 articles


Simultaneous Nailing of Skeletal Metastases: Is the Mortality Really that High?

Bryan Moon MD, Patrick Lin MD, Robert Satcher MD, PhD, Valerae Lewis MD

The risk of death during simultaneous nailing of pathologic and impending fractures in patients with metastatic disease is believed to be so high that some authors have advocated a staged approach, especially for impending fractures. However, there are limited data to either support or refute the appropriateness of staging of multiple impending or pathologic fractures.

Alloprosthetic Composite is a Suitable Reconstruction After Periacetabular Tumor Resection

Davide Donati MD, Claudia Bella MD, Tommaso Frisoni MD, Luca Cevolani MD, Henry DeGroot MD

Resection of a tumor of the pelvis is most disabling when the acetabulum is excised and a durable reconstruction of the defect is hard to achieve. All available methods are associated with frequent complications. Few large series have been published, and fewer have focused entirely on complete resections of the acetabulum. The use of an allograft-prosthetic composite allows customization on the operating table. However, while such composites restore anatomy and function of the pelvis the use of pelvic allografts is controversial and the durability is unknown.

Does Delayed Reexcision Affect Outcome After Unplanned Excision for Soft Tissue Sarcoma?

Ilkyu Han MD, PhD, Hyun Guy Kang MD, PhD, Seung Chul Kang MD, Jay Rim Choi MD, Han-Soo Kim MD, PhD

Unplanned excision of a soft tissue sarcoma generally requires reexcision to achieve an adequate surgical margin. Many surgeons assume delay of definitive surgery adversely affects patient survival and local recurrence. However, no clear evidence of this assumption can be found in the literature.

Orthopaedic Case of the Month: Medial Knee Pain in a 69-year-old Man

Rej S. Bhumbra MBBS, PhD, FRCS (Tr & Orth), Monica Khanna FRCR, Brendan C. Dickson MSc, MD, FRCPC, Peter C. Ferguson MD, MSc, FRCSC

Recurrent Giant Cell Tumor of Long Bones: Analysis of Surgical Management

Frank M. Klenke MD, PhD, Doris E. Wenger MD, Carrie Y. Inwards MD, Peter S. Rose MD, Franklin H. Sim MD

Treatment of giant cell tumor of bone (GCT) often is complicated by local recurrence. Intralesional curettage is the standard of care for primary GCTs. However, there is controversy whether intralesional curettage should be preferred over wide resection in recurrent GCTs.

Giant Cell Tumor of Bone: Risk Factors for Recurrence

Frank M. Klenke MD, PhD, Doris E. Wenger MD, Carrie Y. Inwards MD, Peter S. Rose MD, Franklin H. Sim MD

Many surgeons treat giant cell tumor of bone (GCT) with intralesional curettage. Wide resection is reserved for extensive bone destruction where joint preservation is impossible or when expendable sites (eg, fibular head) are affected. Adjuvants such as polymethylmethacrylate and phenol have been recommended to reduce the risk of local recurrence after intralesional surgery. However, the best treatment of these tumors and risk factors for recurrence remain controversial.

Case Report: Common Femoral Artery Ligation after Sarcoma Resection in an Infant

Luis Aponte-Tinao MD, Germán L. Farfalli MD, Miguel A. Ayerza MD, D. Luis Muscolo MD

Vascular reconstruction in infants constitutes a surgical challenge and is indicated frequently for acute occlusions. With the presence of a subacute vascular occlusion, including that produced by tumor resection, collateral circulation develops quickly. Thus a surgeon can consider tumor and vessel resection, without the need for vascular reconstruction.